NCT07587957 Exploring the Feasibility of an Exercise and Noninvasive Brain Stimulation Intervention in Breast Cancer Survivors
| NCT ID | NCT07587957 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida Atlantic University |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-01-07 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the feasibility of a 4-week intervention combining exercise and transcranial alternating current stimulation (Ex+tACS) in breast cancer survivors who report experiencing cancer-related cognitive impairment. Feasibility will be assessed by measuring participant retention, adherence, satisfaction with the intervention, and safety. The researchers will also examine pre-to-post intervention changes in attention, executive function, working memory, perceived cognitive function, and physical function before, after, and four weeks post intervention completion in the Ex+tACS group compared to a control group who will receive exercise and a placebo tACS condition (CON).
Eligibility Criteria
Inclusion Criteria: * Breast cancer survivors (≥18 years) will be eligible to participate if the following inclusion criteria is met: * Diagnosed non-metastatic breast cancer (stages 0-3) * Completed primary breast cancer treatment (surgery, chemotherapy, radiation) for at least 3 months * Self-reported cognitive impairment after cancer treatment Exclusion Criteria: * Current participation in aerobic exercise for ≥60 min/wk * Contraindication or impairment that precludes the potential participant from exercise as defined by the American College of Sports Medicine * The presence of serious medical illnesses, metal implants, previous brain trauma, epilepsy or history of seizures, previous surgery to the head or spinal cord, or skin problems at the forehead area where the tACS electrodes will be applied * Uncontrolled cardiovascular disease * Functional impairments or physical condition that would make exercise unsafe * Metastatic cancer or diagnosis of a different cancer (excluding melanoma) within the past 5 years * Contraindication to exercise a defined by the American College of Sports Medicine
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07587957 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07587957 currently recruiting?
Yes, NCT07587957 is actively recruiting participants. Contact the research team at aartese@fau.edu for enrollment information.
Where is the NCT07587957 trial being conducted?
This trial is being conducted at Boca Raton, United States.
Who is sponsoring the NCT07587957 clinical trial?
NCT07587957 is sponsored by Florida Atlantic University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.